|
1) National Heart Lung, and Blood Institute/World Health Organization. Global Initiative for Asthma. Global Strategy for Asthma Mnagement and Prevention. Updated 2006. Bethesda: NIH Publicaion; 2006
|
|
|
|
|
2) West JB. In: Pulmonary Pathophysiology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2008
|
|
|
|
|
|
3) Ichinose M, et al. Baseline airway hyper-responsiveness and its reversible component: role of airway inflammation and caliber. Eur Respir J. 2000; 15: 248-53
|
|
|
|
|
4) Brand PLP, Postma DS, Kerstjens HAM, et al. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. Am Rev Respir Dis. 1991; 143: 916-21
|
|
|
|
|
|
5) Ichinose M, Nakajima N, Takahashi T, et al. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet. 1992; 340: 1248-51
|
|
|
|
|
|
6) Black JL. Asthma-more muscle cells or more muscular cells？ Am J Respir Crit Care Med. 2004; 169: 980-1
|
|
|
|
|
|
7) McParland BE, Macklem PT, Pare PD. Airway wall remodeling: friend or foe？ J Appl Physiol. 2003; 95: 426-34
|
|
|
|
|
|
8) Wang L, McParland BE, Pare PD. The functional consequences of structural changes in the airways: implications for airway hyper-responsiveness in asthma. Chest. 2003; 123: 356S-62S
|
|
|
|
|
|
9) Wenzel SE, Busse WW. Severe asthma: lessons from the severe asthma research program. J Allergy Clin Immunol. 2007; 119: 14-21
|
|
|
|
|
|
10) Sugiura H, Komaki Y, Koarai A, et al. Nitrative stress in refractory asthma. J Allergy Clin Immunol. 2008; 121: 355-60
|
|
|
|
|
|
11) Matsunaga K, Kanda M, Hayata A, et al. Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics. Intern Med. 2008; 47: 1107-12
|
|
|
|
|